Sanguiins-Promising Molecules with Broad Biological Potential

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Plant Research

Background:

• Natural products are a rich source of novel bioactive compounds for drug discovery.
• Ellagitannins, specifically sanguiins from the Rosaceae family, are bioactive constituents with therapeutic potential.
• Sanguiin H-6 has demonstrated diverse pharmacological activities, including antimicrobial, antiviral, and anticancer properties.

Purpose of the Study:

• To review naturally occurring ellagitannins, focusing on sanguiins and their biological activities.
• To highlight the potential of sanguiin H-6 as a drug candidate for various ailments.
• To identify future research directions for understanding sanguiins' therapeutic applications.

Main Methods:

• Literature review of studies on sanguiins and their bioactivities.
• Summary of in-depth research on sanguiin H-6's pharmacological effects.
• Inclusion of recent virtual screening findings related to SARS-CoV-2.

Main Results:

• Sanguiin H-6 exhibits significant antimicrobial, antiviral, anticancer, and anti-inflammatory activities.
• Virtual screening suggests sanguiin H-6 may offer early-stage resistance against SARS-CoV-2.
• Sanguiins are identified as promising leads for developing new therapeutic agents.

Conclusions:

• Sanguiins, particularly sanguiin H-6, represent a promising class of natural compounds for drug development.
• Further experimental investigations, including ADMET studies and molecular simulations, are crucial.
• Sanguiins warrant continued research for their application in treating diverse and common diseases.